Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials.

scientific article published on 28 December 2016

Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1200/JCO.2016.69.8944
P932PMC publication ID5455424
P698PubMed publication ID28029312

P50authorCorrinne SegalQ114574877
Simone DetreQ114574878
Jack CuzickQ21005493
Anthony HowellQ37828919
William G. NewmanQ38545164
Adam R BrentnallQ40610182
Ivana SestakQ42801190
Mitch DowsettQ53099690
Elena López-KnowlesQ79297574
Trevor J. PowlesQ114415464
Helen J ByersQ114574855
P2093author name stringCaroline Reuter
P2860cites workAn integrated map of genetic variation from 1,092 human genomesQ22122153
Genome-wide association studies identify four ER negative-specific breast cancer risk lociQ24622610
Genome-wide association study identifies novel breast cancer susceptibility lociQ24645441
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer riskQ27008356
Large-scale genotyping identifies 41 new loci associated with breast cancer riskQ29416989
Hereditary breast cancer: ever more pieces to the polygenic puzzleQ33356511
Breast cancer risk assessment using genetic variants and risk factors in a Singapore Chinese populationQ33892384
Performance of common genetic variants in breast-cancer risk modelsQ34064069
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).Q34085748
Genome-wide association study identifies five new breast cancer susceptibility lociQ34114293
Assessment of clinical validity of a breast cancer risk model combining genetic and clinical informationQ34267477
Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancerQ34631785
A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2.Q35082982
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general populationQ35089479
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancerQ35755874
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancerQ35996692
The contributions of breast density and common genetic variation to breast cancer riskQ36137764
Prediction of breast cancer risk based on profiling with common genetic variantsQ36583004
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensionsQ36615665
Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family RegistryQ36619329
Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trialQ36634556
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer riskQ36720814
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancersQ36742577
Genome-wide association analysis identifies three new breast cancer susceptibility lociQ36842233
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancerQ36897003
Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive modelQ37172219
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.Q37356243
Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.Q37369631
Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association studyQ39006292
Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trials.Q42372951
Multilocus association mapping using variable-length Markov chainsQ42418605
Distribution of breast cancer risk from SNPs and classical risk factors in women of routine screening age in the UK.Q42587251
A concordance index for matched case-control studies with applications in cancer riskQ44325877
Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention.Q50654722
A breast cancer prediction model incorporating familial and personal risk factors.Q52000310
A common coding variant in CASP8 is associated with breast cancer riskQ57250674
Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancerQ57251792
Tamoxifen-Induced Reduction in Mammographic Density and Breast Cancer Risk Reduction: A Nested Case-Control StudyQ59288218
Projecting individualized probabilities of developing breast cancer for white females who are being examined annuallyQ69396132
Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trialQ79803594
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectsingle-nucleotide polymorphismQ501128
tamoxifenQ412178
P304page(s)743-750
P577publication date2016-12-28
P1433published inJournal of Clinical OncologyQ400292
P1476titleImpact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials.
P478volume35

Reverse relations

cites work (P2860)
Q93103805A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density
Q91866775Assessment of breast cancer risk: which tools to use?
Q52586080Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?
Q89746441Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field
Q52672618Clinicians' use of breast cancer risk assessment tools according to their perceived importance of breast cancer risk factors: an international survey.
Q92528444Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification
Q38371172E-Science technologies in a workflow for personalized medicine using cancer screening as a case study
Q55040393Evaluation of three polygenic risk score models for the prediction of breast cancer risk in Singapore Chinese.
Q64080586Genetic Testing to Guide Risk-Stratified Screens for Breast Cancer
Q96302976Key steps for effective breast cancer prevention
Q59349295Progress in preventive therapy for cancer: a reminiscence and personal viewpoint
Q90744442Risk Models for Breast Cancer and Their Validation
Q54950358Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data.
Q92993050Systematic evaluation of cancer-specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts
Q92755500Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy miRNA Profiles to Breast Cancer Disease Management
Q55385618ZNF423: A New Player in Estrogen Receptor-Positive Breast Cancer.

Search more.